iBio, Inc.
IBIO
$0.818
$0.0253.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 650.00% | 650.00% | 250.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 650.00% | 650.00% | 250.00% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 650.00% | 650.00% | 250.00% | -- | -- |
| SG&A Expenses | -7.42% | -15.29% | -37.46% | -38.61% | -49.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.77% | -23.33% | -41.13% | -42.55% | -47.63% |
| Operating Income | 7.57% | 24.95% | 41.67% | 43.31% | 47.78% |
| Income Before Tax | 3.91% | 31.48% | 46.52% | 47.31% | 50.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.91% | 31.48% | 46.52% | 47.31% | 50.73% |
| Earnings from Discontinued Operations | 24.88% | 22.15% | 65.89% | 73.49% | 85.38% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.37% | 29.25% | 56.01% | 61.69% | 69.54% |
| EBIT | 7.57% | 24.95% | 41.67% | 43.31% | 47.78% |
| EBITDA | 7.12% | 25.86% | 43.10% | 45.14% | 49.69% |
| EPS Basic | 86.33% | 90.12% | 92.73% | 91.39% | 89.28% |
| Normalized Basic EPS | 86.46% | 89.45% | 89.64% | 85.09% | 81.36% |
| EPS Diluted | 86.33% | 90.11% | 92.73% | 91.39% | 89.28% |
| Normalized Diluted EPS | 86.46% | 89.45% | 89.64% | 85.09% | 81.36% |
| Average Basic Shares Outstanding | 374.89% | 557.65% | 610.92% | 526.76% | 276.08% |
| Average Diluted Shares Outstanding | 374.89% | 557.65% | 610.92% | 526.76% | 276.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |